Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fixed Dose Intervention Trial of New England Enhancing Survival in Serious Mental Illness Patients

NCT02188121 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.

NCT NCT02188121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02188121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fixed Dose Intervention Trial of New England Enhancing Survival in Serious Mental Illness Patients
Lead sponsor
Mclean Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2015
Completion date
October 31, 2021
Enrollment
227 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, cardiovascular disease, major depressive disorder, psychosis nos, schizoaffective disorder, schizophrenia, serious mental illness